Koichi Ichimura

发表

Concurrent Hodgkin’s Disease (Mixed Cellularity Type) and T-Cell Chronic Lymphocytic Leukemia/Prolymphocytic Leukemia

T. Yoshino, K. Ichimura, K. Kojima, 2001, International journal of hematology.

Increased incidence of follicular lymphoma in the duodenum.

T. Yoshino, K. Ichimura, T. Akagi, 2000, The American journal of surgical pathology.

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

V. P. Collins, M. Wolter, G. Reifenberger, 2001, The American journal of pathology.

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

G. Reifenberger, K. Ichimura, E. E. Schmidt, 1994, Cancer research.

Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

V P Collins, K. Ichimura, H. Goike, 1996, Oncogene.

Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas

K. Ichimura, L. M. Bäcklund, L. Liu, 2005, British Journal of Cancer.

Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

P. Meltzer, G. Reifenberger, A. Elkahloun, 1996, Cancer research.

1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas

V. P. Collins, C. Langford, S. Gregory, 2008, Oncogene.

Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4‐MB constitutional deletion on chromosome 22: Possible localization of a neurofibromatosis type 2 modifier gene?

E. Blennow, C. Bruder, J. Dumanski, 1999, Genes, chromosomes & cancer.

Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours

V. P. Collins, K. Ichimura, S. Varmeh-Ziaie, 2000, British Journal of Cancer.

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

K. Ichimura, H. Goike, A. Moshref, 2000, Cancer research.

p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours

D. Pearson, K. Ichimura, L. M. Bäcklund, 2008, British Journal of Cancer.

Epidermal growth factor receptor expression in oligodendroglial tumors.

V. P. Collins, G. Reifenberger, K. Ichimura, 1996, The American journal of pathology.